Skip to main content
    N

    National Research Corp (NRC)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $23.83
    +0.34 (+1.45%)

    Market Cap: $505.71M

    Last updated: Oct 30, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    78%(14/18)
    Avg Surprise
    +1.81%
    Streak
    9 Q

    Upcoming Estimates

    Period ending Mar 31, 2027
    EPS Consensus$0.23
    Range$0.23 - $0.23
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.24-4.2%
    60d ago$0.24-4.2%
    30d ago$0.24-4.2%
    7d ago$0.24-4.2%
    Current$0.23
    Revenue Consensus
    $37M
    Range$37M - $37M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Mar 27EST
    		-$0.23---
    Sep 26
    Reported Oct 27
    		$0.21$0.21+0.00%Beat+16.3%
    Jun 26
    Reported Jul 28
    		$0.31$0.14+121.43%Beat+3200.0%
    Mar 26
    Reported Apr 28
    		$0.14N/AN/ABeat-44.0%
    Dec 25
    Reported Feb 3
    		$0.08$0.00N/ABeat-70.7%
    Sep 25
    Reported Oct 27
    		$0.18$0.00N/ABeat-24.6%
    Jun 25
    Reported Jul 28
    		$-0.01$0.00N/AMiss-103.9%
    Mar 25
    Reported Apr 28
    		$0.25N/AN/ABeat-5.1%
    Dec 24
    Reported Feb 11
    		$0.28N/AN/ABeat-22.0%
    Sep 24
    Reported Oct 25
    		$0.24N/AN/ABeat-25.2%
    Jun 24
    Reported Aug 6
    		$0.26N/AN/ABeat-11.0%
    Mar 24
    Reported May 7
    		$0.27N/AN/ABeat-5.3%
    Dec 23
    Reported Feb 13
    		$0.36$0.36+0.00%Beat+33.3%
    Sep 23
    Reported Nov 7
    		$0.32$0.32+0.00%Beat-3.0%
    Jun 23
    Reported Aug 1
    		$0.29$0.29+0.00%Beat-12.1%
    Mar 23
    Reported May 2
    		$0.28N/AN/ABeat-17.6%
    Dec 22
    Reported Feb 14
    		$0.27N/AN/ABeat-28.9%
    Sep 22
    Reported Nov 1
    		$0.33N/AN/ABeat-13.2%
    Jun 22
    Reported Aug 2
    		$0.33N/AN/ABeat-5.7%
    Mar 22
    Reported May 3
    		$0.34N/AN/ABeat-5.6%
    Dec 21
    Reported Feb 8
    		$0.38N/AN/ABeat+18.8%
    Sep 21
    Reported Nov 2
    		$0.38N/AN/ABeat+2.7%
    Jun 21
    Reported Aug 3
    		$0.35N/AN/ABeat+16.7%
    Mar 21
    Reported May 4
    		$0.36N/AN/ABeat-21.7%
    Dec 20
    Reported Feb 9
    		$0.32N/AN/ABeat-5.9%
    Sep 20
    Reported Nov 3
    		$0.37N/AN/ABeat+19.4%
    Jun 20
    Reported Aug 4
    		$0.30N/AN/ABeat+3.4%
    Mar 20
    Reported May 5
    		$0.46N/AN/ABeat+43.8%
    Dec 19
    Reported Feb 11
    		$0.34$0.30+13.33%Beat+13.3%
    Sep 19
    Reported Nov 5
    		$0.31$0.29+6.90%Beat+14.8%
    Jun 19
    Reported Aug 6
    		$0.29$0.26+11.54%Beat+3.6%
    Mar 19
    Reported May 7
    		$0.32$0.31+3.23%Beat+10.3%
    Dec 18
    Reported Feb 12
    		$0.30N/A-71.43%Miss+100.0%
    Sep 18
    Reported Nov 6
    		$0.27N/A-72.45%Miss+68.8%
    Jun 18
    Reported Aug 7
    		$0.28$0.22+27.27%Beat+21.7%
    Mar 18
    Reported May 1
    		$0.29$0.25+16.00%Beat+11.5%
    Dec 17
    Reported Feb 13
    		$0.15$0.22-31.82%Miss-37.5%
    Sep 17
    Reported Nov 7
    		$0.16$0.21-23.81%Miss-
    Jun 17
    Reported Aug 1
    		$0.23$0.20+15.00%Beat-
    Mar 17
    Reported May 2
    		$0.26$0.24+8.33%Beat-
    Dec 16
    Reported Feb 21
    		$0.24$0.22+9.09%Beat-

    Dividends

    Dividend Metrics

    Forward Yield2.69%
    Forward Annual Dividend$0.64
    Payout Ratio47.73%
    FrequencyQuarterly
    Pay MonthsJan, Apr, Jul, Oct

    Growth

    3Y CAGR-14.77%
    5Y CAGR+19.88%
    NRC dividend history and ex-dividend datesRun NRC in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio32.06EV/EBITDA26.12x
    Price/FCF24.24xFCF Yield4.13%
    Profitability
    Profit Margin4.48%Operating Margin23.20%
    ROE248.10%ROIC9.87%
    Financial Health
    Debt/Equity13.75xInterest Coverage2.71x
    Current Ratio0.65xQuick Ratio0.65x
    Trading Statistics
    Beta0.28Avg Volume94.58K
    52-Week High$24.4052-Week Low$11.45

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$21.98
    SMA 20$21.19
    SMA 50$21.13
    SMA 200$18.98
    EMA 10$22.33
    EMA 20$21.68
    EMA 50$21.15
    EMA 200$19.25

    MACD

    Line: 0.64Signal: 0.27Hist: 0.37

    ADX

    ADX: 20.0+DI: 29.8-DI: 10.5

    Aroon & PSAR

    Aroon Up96.0
    Aroon Down4.0
    PSAR$20.86

    Bollinger Bands

    Upper Band$23.64
    Lower Band$18.74
    %B Position2313%(Upper)
    Band Width1.04

    RSI (14-Day)

    Neutral
    66.9

    Momentum Oscillators

    Stoch %K85.8
    Stoch %D80.9
    Williams %R-12.9
    ROC (10d)18.3%
    Momentum3.68
    CCI (20d)181.5
    MFI (14d)79.3

    Volatility Measures

    ATR (14d)$0.98(4.1%)
    StdDev (20d)1.23
    Hist Vol46.1%(High)

    Volume Flow

    VWAP$23.77
    OBV6.3M
    AD Line-34.8M
    CMF (20d)0.105

    Volume Metrics

    Avg Vol (20d)89.0K
    Vol Ratio1.0x
    VWMA (20d)$21.54

    Pivot Points

    R3$25.22
    R2$24.81
    R1$24.15
    Pivot Point$23.74
    S1$23.08
    S2$22.67
    S3$22.01

    Advanced Oscillators

    TSI17.72
    Ultimate Osc59.3
    KST47.41

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$35.39M$34.80M$35.19M$34.61M$34.04M$33.55M$36.91M$35.82M$35.02M$35.31M$38.00M$37.95M
    Cost of Revenue$0$0$16.08M$0$0$0$14.35M$0$0$0$13.79M$0
    Gross Profit$35.39M$34.80M$35.19M$34.61M$34.04M$33.55M$36.91M$35.82M$35.02M$35.31M$38.00M$37.95M
    Operating Expenses$38.63M$29.23M$30.52M$26.87M$32.45M$24.95M$27.32M$27.84M$26.16M$26.55M$26.29M$27.99M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$22.95M$13.42M$14.44M$12.27M$17.73M$10.36M$11.45M$10.99M$11.22M$11.25M$11.07M$11.80M
    Operating Income$-3,238,000$5.57M$4.67M$7.74M$1.59M$8.60M$9.59M$7.98M$8.87M$8.76M$11.71M$9.96M
    Interest Income$20,000$35,000$30,000$41,000$21,000$19,000$22,000$34,000$25,000$44,000$41,000$256,000
    Interest Expense$1.32M$1.25M$1.37M$1.46M$1.03M$899,000$729,000$706,000$555,000$605,000$269,000$160,000
    Income Before Tax$-4,537,000$4.38M$3.27M$6.27M$581,000$7.72M$8.88M$7.30M$8.32M$8.19M$11.47M$10.04M
    Income Tax Expense$-1,254,000$1.16M$1.47M$2.15M$687,000$1.94M$2.31M$1.61M$2.15M$1.83M$2.61M$2.16M
    Net Income$-3,283,000$3.22M$1.80M$4.12M$-106,000$5.79M$6.56M$5.69M$6.17M$6.36M$8.86M$7.88M
    EBITDA$-1,088,000$7.79M$6.78M$9.92M$3.37M$10.16M$11.10M$9.53M$10.38M$10.21M$13.13M$11.50M
    EBIT$-3,236,000$5.60M$4.61M$7.69M$1.59M$8.60M$9.58M$7.97M$8.85M$8.76M$11.70M$9.94M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NRC

    News

    National Research Corporation (NRC) Reports In-Line Q3 EPS

    National Research Corporation (NASDAQ: NRC) announced its Q3 earnings, reporting an EPS of $0.21, which matched analyst estimates. The company's revenue for the quarter was $38.4 million...

    StreetInsider•10/27/26•Neutral

    National Research Q3 Earnings Call Highlights

    National Research (NRC Health) reported an 11% increase in Q3 revenue to $38 million, driven by a major customer implementation and broad portfolio growth. Adjusted EBITDA reached $10.9 million, a 28% margin...

    TradingView•10/27/26•Bullish

    National Research Q3 2026 Earnings Call Transcript

    National Research (NASDAQ: NRC) reported a strong Q2 2026, with a 4% year-over-year revenue increase and 11% growth in Total Recurring Contract Value (TRCV). The company highlighted strategic investments in product...

    Benzinga•10/27/26•Neutral

    Nantucket Cottage Hospital Recognized For Excellence In Patient Experience

    Nantucket Cottage Hospital has been recognized by NRC Health for excellence in patient experience within the 'Small Hospital' category. This award highlights the hospital's dedication to providing exceptional care...

    Nantucket Current•10/27/26•Neutral

    Discipline and Rules-Based Execution in NRC Response

    This article from Stock Traders Daily provides a detailed analysis of National Research Corporation (NYSE: NRC)...

    Stock Traders Daily•10/23/26•Somewhat-Bullish

    NRC Valuation and Fair Value

    P/E
    32.1x
    Forward P/E
    17.2x
    EV/EBITDA
    26.1x
    P/FCF
    24.2x
    PEG
    1.3x
    P/B
    80.1x
    See GNG's fair value

    NRC Profitability: Margins, ROIC and FCF

    Gross margin
    100.0%
    Operating margin
    23.2%
    Net margin
    4.5%
    ROIC
    9.9%
    ROE
    248.1%
    FCF yield
    4.1%

    NRC Competitors

    CompanyTicker
    Surrozen IncSRZN
    AngioDynamics IncANGO
    Oculis Holding AG Ordinary sharesOCS
    Ovid Therapeutics IncOVID
    Oncology Institute IncTOI
    CytomX Therapeutics IncCTMX
    Sight Sciences IncSGHT
    DiaMedica Therapeutics IncDMAC

    Sector: Healthcare

    NRC Bull Case vs Bear Case

    Bull case

    • NRC grew quarterly revenue 11.0% year over year.

    Bear case

    • NRC beat EPS estimates in 37.5% of its last 8 reported quarters.
    • NRC has a debt-to-equity ratio of 13.7x.

    NRC Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    24.3%
    EPS estimate (fiscal period ending Mar 31, 2027)
    $0.23
    Estimate revisions (30 days, fiscal period ending Mar 31, 2027)
    0 up, 0 down

    NRC Dividend

    Forward yield
    2.7%
    Payout ratio
    47.7%
    3Y DPS growth
    -14.8%
    5Y DPS growth
    19.9%
    Pay months
    Jan, Apr, Jul, Oct
    NRC dividend history

    Frequently Asked Questions About NRC

    What is NRC's current dividend yield?

    National Research Corp (NRC) has a forward dividend yield of 2.69%.

    Does NRC pay dividends?

    Yes, National Research Corp pays dividends with a forward dividend yield of 2.69%.

    What is NRC's P/E ratio?

    National Research Corp has a price-to-earnings (P/E) ratio of 32.06.

    What is NRC's market cap?

    National Research Corp (NRC) has a market capitalization of $505.71M with a current stock price of $23.83.

    Related stocks

    Sector: Healthcare

    All stocks starting with N

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In